Perrigo Laboratories India Private Limited

Develops and manufactures pharmaceutical and nutritional products for global distribution.

2005 | Thane, Maharashtra (India) | Converted to LLP
Last Updated: April 25, 2024

Perrigo Laboratories India Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.21 M
  • Company Age 19 Year, 11 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 5.00 M
  • Revenue Growth -3.24%
  • Profit Growth -19.98%
  • Ebitda -1.42%
  • Net Worth 7.07%
  • Total Assets 9.41%

About Perrigo Laboratories India

Perrigo Laboratories India Private Limited (PLIPL) is Converted To Llp company established on 23 Feb 2005 with its office registered at Thane, Maharashtra, India and has been running since 19 Year, 11 Months with a paid up capital of 0.21 M. According to MCA records, 2 Directors are linked to this company as of 25 Apr 2024.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website
  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230MH2005PTC240217

  • Company No.

    240217

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    23 Feb 2005

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Perrigo Laboratories India Private Limited offer?

Perrigo Laboratories India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements.

Who are the key members and board of directors at Perrigo Laboratories India?

Board Members (2)

Name Designation Appointment Date Status
Sumedha Sanjeev Country flag representing In Whole-Time Director 25-Feb-2015 Current
James Iii Country flag representing Us Director 21-Sep-2020 Current

Financial Performance of Perrigo Laboratories India.

Perrigo Laboratories India Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.24% decrease. The company also saw a substantial fall in profitability, with a 19.98% decrease in profit. The company's net worth moved up by a moderate rise of 7.07%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-3.24%
Revenue from Operations
0.30%
Total Assets
9.41%
Profit or Loss
-19.98%
Net Worth
7.07%
EBITDA
-1.42%

What is the Ownership and Shareholding Structure of Perrigo Laboratories India?

In 2022, Perrigo Laboratories India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹5.00 M

Charges Breakdown by Lending Institutions

  • The Hongkong And Shanghai Banking Corporation Limited : 0.50 Cr

Latest Charge Details

Date Lender Amount Status
21 Nov 2014 The Hongkong And Shanghai Banking Corporation Limited ₹5.00 M Satisfied

How Many Employees Work at Perrigo Laboratories India?

Perrigo Laboratories India has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Perrigo Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perrigo Laboratories India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Perrigo Laboratories India

Recent activity within the organization

  • Charges

    A charge registered on 21 Nov 2014 via Charge ID 10544514 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 30 Nov 2022.

    30 Nov 2022

  • Annual General Meeting

    Perrigo Laboratories India Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Balance Sheet

    Perrigo Laboratories India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai.

    31 Mar 2022

  • Director Appointment

    James Edwin Dillard Iii was appointed as a Director was appointed as a Director on 21 Sep 2020 & has been associated with this company since 4 years 4 months .

    21 Sep 2020

  • Director Appointment

    Sumedha Nadkar Sanjeev was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 25 Feb 2015 & has been associated with this company since 9 years 11 months .

    25 Feb 2015

  • Charges

    A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 5.00 M with Charge ID 10544514 was registered on 21 Nov 2014.

    21 Nov 2014

Recent News, Updates & Announcement

Frequently asked questions

  • Perrigo Laboratories India Private Limited was incorporated on 23 Feb 2005.

  • The authorized share capital of Perrigo Laboratories India Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.21 M.

  • Currently 2 directors are associated with Perrigo Laboratories India Private Limited.

    • Sumedha Nadkar Sanjeev
    • James Edwin Dillard Iii
  • As per Ministry of Corporate Affairs (Mca), the registered address of Perrigo Laboratories India Private Limited is Plot No. N-39 And Plot No. N-39/1 Additional, Ambernath Midc Anand Nagar Ambernath (East), Thane, Maharashtra, India, 421506.

  • The corporate identification number (CIN) of Perrigo Laboratories India Private Limited is U24230MH2005PTC240217 and the company number is 240217 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Perrigo Laboratories India Private Limited is https://www.perrigo.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Perrigo Laboratories India Private Limited has fallen by -3.24%.

  • As Per 2021 financial reports, 25 employees are currently employed by Perrigo Laboratories India Private Limited.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Perrigo Laboratories India Private Limited has experienced an upsurge of 7.07%.

  • The most recent Balance Sheet for Perrigo Laboratories India Private Limited was filed with the ROC on 31 Mar 2022.

Similar Companies Based on Pharma Contract R&D